Tests the VisiPlate eye implant in people with hard-to-treat open-angle glaucoma
Tests the VisiPlate eye implant in adults with glaucoma that has not responded to treatment.
Plain-language title generated from the registry record
Registry title: Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
Key facts
- Where
- Dallas, Glendale, Grand Junction, Houston, Kenosha, Los Angeles, New York, Petaluma, Philadelphia, and Sacramento, United StatesSee the 12 sites
Where in United States
- Glaucoma Associates of TexasDallas, United StatesTaking people
- University of Texas, SouthwesternDallas, United StatesTaking people
- Arizona Advanced Eye ResearchGlendale, United StatesTaking people
- ICON Eye CareGrand Junction, United StatesTaking people
- Houston Eye AssociatesHouston, United StatesTaking people
- The Eye Centers of Racine & KenoshaKenosha, United StatesTaking people
- Advanced Vision CareLos Angeles, United StatesNo longer taking part
- NYC RetinaNew York, United StatesTaking people
- North Bay Eye Associates, Inc.Petaluma, United StatesTaking people
- Scheie Eye InstitutePhiladelphia, United StatesTaking people
- Wills Eye HospitalPhiladelphia, United StatesNo longer taking part
- Sacramento Eye ConsultantsSacramento, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Avisi Technologies Inc.
- Trial code
- NCT07220876
- Record updated
- 7 October 2026
- Original description
A Prospective, Multicenter, Single-Arm, Open-Label Clinical TrialRead full original descriptionShow less
A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial of the Safety and Effectiveness of the VisiPlate Aqueous Shunt in Patients With Refractory Open-Angle Glaucoma
A Prospective, Multicenter, Single-Arm, Open-Label Clinical Trial
Inclusion: Open angle, pseudoexfoliative or pigmentary glaucoma; IOP at preoperative visit of ≥ 20mmHg and ≤ 40mmHg; Visual field mean deviation score of -3dB or worse; Area of healthy, free and mobile conjunctiva in the target quadrant; Shaffer angle grade ≥ 2 in the target quadrant.
Exclusion: Previous intraocular surgery, with the exception of uncomplicated cataract surgery; Previous glaucoma shunt/valve in the target quadrant; Clinically significant inflammation or infection in the study eye within 30 days prior to the operative visit; History of corneal surgery, corneal opacities or corneal disease; Retinal or optic nerve disorders, either degenerative or evolutive, that are not associated with the existing glaucoma condition; Angle closure glaucoma; Congenital, neovascular or other secondary glaucomas.